Browsing: Review
Jacques LOIC X4 Pharmaceuticals (NASDAQ:XFOR) announced Friday that the EU regulators agreed to review its marketing authorization application for mavorixafor,…
The government has launched its promised independent review into the loan charge but has been met with criticism from campaigners…
Professor25 The U.S. FDA has granted priority review to Verastem Oncology’s (NASDAQ:VSTM) combination of avutometinib and defactinib for a type…
Elon Musk’s leadership of the Department of Government Efficiency (DOGE) is under scrutiny following Vivek Ramaswamy’s departure to pursue political…
XRP inches closer to overtaking ETH, Crypto inaugural Ball, Trump’s first-day Executive Orders and more in this Week in Review.…
Major crypto developments across Africa, with significant progress this week, have taken place. Kenya took a crucial step towards regulating…
Strict rules on mortgage lending could be loosened to allow more people to borrow for a home, as regulators respond…
Meet Samuel Edyme, Nickname – HIM-buktu. A web3 content writer, journalist, and aspiring trader, Edyme is as versatile as they…
Private parking firms have pledged to update their to rules to ensure motorists are not penalised if they do not…
This week has been eventful for the crypto industry. The U.S. Department of Justice’s clearance to liquidate 69,000 Bitcoin, caused…